Clinical Trials Directory

Trials / Completed

CompletedNCT00318851

Carotid Artery Stenting With Protection Registry

Treatment of Carotid Stenosis With Carotid Stenting and Neurologic Protection With Pre-Procedure and Follow-Up With MRI DIffusion Imaging and Neuropsychological Testing

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
62 (actual)
Sponsor
Providence Health & Services · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate ischemic events and neuropsychological changes after carotid artery angioplasty and stenting with a neuroprotection device.

Detailed description

Stroke is the third most common cause of death in North America with approximately 750,000 new strokes reported annually, of which 150,000 are fatal. Approximately 75% of strokes occur in the distribution of the carotid arteries. Among those, a thrombotic etiology (carotid occlusive disease) is one of the most common causes. Recently published studies have shown that patients who underwent carotid stenting in combination with a cerebral protection device had better overall outcomes as related to stroke, death and MI as opposed to carotid endarterectomy. What is not known is whether protection devices which allow some particles (100 micron particle size or less) to pass through the filter or particles that embolize during placement or removal of the protection device, will have any delayed abnormal outcomes as determined by neuropsychological testing.

Conditions

Interventions

TypeNameDescription
DEVICECarotid Stent with Distal Protection DeviceCarotid Stent Placement with Distal Protection

Timeline

Start date
2003-09-01
Primary completion
2007-08-01
Completion
2007-08-01
First posted
2006-04-27
Last updated
2010-08-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00318851. Inclusion in this directory is not an endorsement.